Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy

Yu Ping Liu, Lukkana Suksanpaisan, Michael B. Steele, Stephen J Russell, Kah-Whye Peng

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Oncolytic viruses obliterate tumor cells in tissue culture but not against the same tumors in vivo. We report that macrophages can induce a powerfully protective antiviral state in ovarian and breast tumors, rendering them resistant to oncolytic virotherapy. These tumors have activated JAK/STAT pathways and expression of interferon-stimulated genes (ISGs) is upregulated. Gene expression profiling (GEP) of human primary ovarian and breast tumors confirmed constitutive activation of ISGs. The tumors were heavily infiltrated with CD68+ macrophages. Exposure of OV-susceptible tumor cell lines to conditioned media from RAW264.7 or primary macrophages activated antiviral ISGs, JAK/STAT signaling and an antiviral state. Anti-IFN antibodies and shRNA knockdown studies show that this effect is mediated by an extremely low concentration of macrophage-derived IFNβ. JAK inhibitors reversed the macrophage-induced antiviral state. This study points to a new role for tumor-associated macrophages in the induction of a constitutive antiviral state that shields tumors from viral attack.

Original languageEnglish (US)
Article number2375
JournalScientific Reports
Volume3
DOIs
StatePublished - 2013

Fingerprint

Tumor Microenvironment
Antiviral Agents
Macrophages
Interferons
Genes
Neoplasms
Oncolytic Virotherapy
Oncolytic Viruses
Breast Neoplasms
Gene Expression Profiling
Conditioned Culture Medium
Tumor Cell Line
Small Interfering RNA
Anti-Idiotypic Antibodies

ASJC Scopus subject areas

  • General
  • Medicine(all)

Cite this

Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy. / Liu, Yu Ping; Suksanpaisan, Lukkana; Steele, Michael B.; Russell, Stephen J; Peng, Kah-Whye.

In: Scientific Reports, Vol. 3, 2375, 2013.

Research output: Contribution to journalArticle

@article{aac4e55761174fec9b896b8339efbc19,
title = "Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy",
abstract = "Oncolytic viruses obliterate tumor cells in tissue culture but not against the same tumors in vivo. We report that macrophages can induce a powerfully protective antiviral state in ovarian and breast tumors, rendering them resistant to oncolytic virotherapy. These tumors have activated JAK/STAT pathways and expression of interferon-stimulated genes (ISGs) is upregulated. Gene expression profiling (GEP) of human primary ovarian and breast tumors confirmed constitutive activation of ISGs. The tumors were heavily infiltrated with CD68+ macrophages. Exposure of OV-susceptible tumor cell lines to conditioned media from RAW264.7 or primary macrophages activated antiviral ISGs, JAK/STAT signaling and an antiviral state. Anti-IFN antibodies and shRNA knockdown studies show that this effect is mediated by an extremely low concentration of macrophage-derived IFNβ. JAK inhibitors reversed the macrophage-induced antiviral state. This study points to a new role for tumor-associated macrophages in the induction of a constitutive antiviral state that shields tumors from viral attack.",
author = "Liu, {Yu Ping} and Lukkana Suksanpaisan and Steele, {Michael B.} and Russell, {Stephen J} and Kah-Whye Peng",
year = "2013",
doi = "10.1038/srep02375",
language = "English (US)",
volume = "3",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Induction of antiviral genes by the tumor microenvironment confers resistance to virotherapy

AU - Liu, Yu Ping

AU - Suksanpaisan, Lukkana

AU - Steele, Michael B.

AU - Russell, Stephen J

AU - Peng, Kah-Whye

PY - 2013

Y1 - 2013

N2 - Oncolytic viruses obliterate tumor cells in tissue culture but not against the same tumors in vivo. We report that macrophages can induce a powerfully protective antiviral state in ovarian and breast tumors, rendering them resistant to oncolytic virotherapy. These tumors have activated JAK/STAT pathways and expression of interferon-stimulated genes (ISGs) is upregulated. Gene expression profiling (GEP) of human primary ovarian and breast tumors confirmed constitutive activation of ISGs. The tumors were heavily infiltrated with CD68+ macrophages. Exposure of OV-susceptible tumor cell lines to conditioned media from RAW264.7 or primary macrophages activated antiviral ISGs, JAK/STAT signaling and an antiviral state. Anti-IFN antibodies and shRNA knockdown studies show that this effect is mediated by an extremely low concentration of macrophage-derived IFNβ. JAK inhibitors reversed the macrophage-induced antiviral state. This study points to a new role for tumor-associated macrophages in the induction of a constitutive antiviral state that shields tumors from viral attack.

AB - Oncolytic viruses obliterate tumor cells in tissue culture but not against the same tumors in vivo. We report that macrophages can induce a powerfully protective antiviral state in ovarian and breast tumors, rendering them resistant to oncolytic virotherapy. These tumors have activated JAK/STAT pathways and expression of interferon-stimulated genes (ISGs) is upregulated. Gene expression profiling (GEP) of human primary ovarian and breast tumors confirmed constitutive activation of ISGs. The tumors were heavily infiltrated with CD68+ macrophages. Exposure of OV-susceptible tumor cell lines to conditioned media from RAW264.7 or primary macrophages activated antiviral ISGs, JAK/STAT signaling and an antiviral state. Anti-IFN antibodies and shRNA knockdown studies show that this effect is mediated by an extremely low concentration of macrophage-derived IFNβ. JAK inhibitors reversed the macrophage-induced antiviral state. This study points to a new role for tumor-associated macrophages in the induction of a constitutive antiviral state that shields tumors from viral attack.

UR - http://www.scopus.com/inward/record.url?scp=84881414523&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881414523&partnerID=8YFLogxK

U2 - 10.1038/srep02375

DO - 10.1038/srep02375

M3 - Article

C2 - 23921465

AN - SCOPUS:84881414523

VL - 3

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 2375

ER -